Examining trends in substance use disorder capacity and service delivery by Health Resources and Services Administration-funded health centers: A time series regression analysis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 07 01 2020
accepted: 02 11 2020
entrez: 30 11 2020
pubmed: 1 12 2020
medline: 7 1 2021
Statut: epublish

Résumé

The opioid epidemic and subsequent mortality is a national concern in the U.S. The burden of this problem is disproportionately high among low-income and uninsured populations who are more likely to experience unmet need for substance use services. We assessed the impact of two Health Resources and Services Administration (HRSA) substance use disorder (SUD) service capacity grants on SUD staffing and service use in HRSA -funded health centers (HCs). We conducted cross-sectional analyses of the Uniform Data System (UDS) from 2010 to 2017 to assess HC (n = 1,341) trends in capacity measured by supply of SUD and medication-assisted treatment (MAT) providers, utilization of SUD and MAT services, and panel size and visit ratio measured by the number of patients seen and visits delivered by SUD and MAT providers. We merged mortality and national survey data to incorporate SUD mortality and SUD treatment services availability, respectively. From 2010 to 2015, 20% of HC organizations had any SUD staff, had an average of one full-time equivalent SUD employee, and did not report an increase in SUD patients or SUD services. SUD capacity grew significantly in 2016 (43%) and 2017 (22%). MAT capacity growth was measured only in 2016 and 2017 and grew by 29% between those years. Receipt of both supplementary grants increased the probability of any SUD capacity by 35% (95% CI: 26%, 44%) and service use, but decreased the probability of SUD visit ratio by 680 visits (95% CI: -1,013, -347), compared to not receiving grants. The significant growth in HC specialized SUD capacity is likely due to supplemental SUD-specific HRSA grants and may vary by structure of grants. Expanding SUD capacity in HCs is an important step in increasing SUD access for low income and uninsured populations broadly and for patients of these organizations.

Sections du résumé

BACKGROUND
The opioid epidemic and subsequent mortality is a national concern in the U.S. The burden of this problem is disproportionately high among low-income and uninsured populations who are more likely to experience unmet need for substance use services. We assessed the impact of two Health Resources and Services Administration (HRSA) substance use disorder (SUD) service capacity grants on SUD staffing and service use in HRSA -funded health centers (HCs).
METHODS AND FINDINGS
We conducted cross-sectional analyses of the Uniform Data System (UDS) from 2010 to 2017 to assess HC (n = 1,341) trends in capacity measured by supply of SUD and medication-assisted treatment (MAT) providers, utilization of SUD and MAT services, and panel size and visit ratio measured by the number of patients seen and visits delivered by SUD and MAT providers. We merged mortality and national survey data to incorporate SUD mortality and SUD treatment services availability, respectively. From 2010 to 2015, 20% of HC organizations had any SUD staff, had an average of one full-time equivalent SUD employee, and did not report an increase in SUD patients or SUD services. SUD capacity grew significantly in 2016 (43%) and 2017 (22%). MAT capacity growth was measured only in 2016 and 2017 and grew by 29% between those years. Receipt of both supplementary grants increased the probability of any SUD capacity by 35% (95% CI: 26%, 44%) and service use, but decreased the probability of SUD visit ratio by 680 visits (95% CI: -1,013, -347), compared to not receiving grants.
CONCLUSIONS
The significant growth in HC specialized SUD capacity is likely due to supplemental SUD-specific HRSA grants and may vary by structure of grants. Expanding SUD capacity in HCs is an important step in increasing SUD access for low income and uninsured populations broadly and for patients of these organizations.

Identifiants

pubmed: 33253263
doi: 10.1371/journal.pone.0242407
pii: PONE-D-20-00610
pmc: PMC7703936
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0242407

Déclaration de conflit d'intérêts

The authors have read the journal's policy, and the authors of this manuscript have the following competing interests to declare: MD, HH, and AS are employees of the U.S. Government, U.S. Department of Health and Human Services, which funded this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Health Serv Res. 2014 Apr;49(2):666-82
pubmed: 24117318
Ann Intern Med. 2004 Apr 6;140(7):554-6
pubmed: 15068984
J Subst Abuse Treat. 2018 Jul;90:64-72
pubmed: 29866385
Am J Public Health. 2015 Oct;105(10):2028-34
pubmed: 26270310
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427
pubmed: 30605448
Med Care. 2016 Oct;54(10):901-6
pubmed: 27623005
J Addict Med. 2016 Nov/Dec;10(6):387-394
pubmed: 27753718
Health Aff (Millwood). 2007 Sep-Oct;26(5):1459-68
pubmed: 17848458
J Couns Psychol. 2013 Oct;60(4):610-6
pubmed: 23815630
J Rural Health. 2018 Dec;34(1):14-22
pubmed: 28842930
J Behav Health Serv Res. 2017 Jan;44(1):63-74
pubmed: 27812852
Psychiatr Serv. 2020 Jul 1;71(7):684-690
pubmed: 32438889
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
MMWR Morb Mortal Wkly Rep. 2018 Mar 09;67(9):279-285
pubmed: 29518069
Psychiatr Serv. 2015 Dec 1;66(12):1277-82
pubmed: 26278224
Adm Policy Ment Health. 2017 Jul;44(4):492-500
pubmed: 26238475
Eval Program Plann. 2009 Feb;32(1):43-51
pubmed: 19019434
J Psychoactive Drugs. 2012 Sep-Oct;44(4):299-306
pubmed: 23210378
Health Aff (Millwood). 2010 Feb;29(2):289-96
pubmed: 20348076
N Engl J Med. 2015 Feb 19;372(8):698-701
pubmed: 25693009
Ann Intern Med. 2017 Feb 21;166(4):268-278
pubmed: 27919103
J Behav Health Serv Res. 2013 Oct;40(4):488-96
pubmed: 23963817

Auteurs

Nadereh Pourat (N)

Center for Health Policy Research, University of California, Los Angeles (UCLA), Los Angeles, CA, United States of America.
Fielding School of Public Health, UCLA, Los Angeles, CA, United States of America.

Brenna O'Masta (B)

Center for Health Policy Research, University of California, Los Angeles (UCLA), Los Angeles, CA, United States of America.

Xiao Chen (X)

Center for Health Policy Research, University of California, Los Angeles (UCLA), Los Angeles, CA, United States of America.

Connie Lu (C)

Center for Health Policy Research, University of California, Los Angeles (UCLA), Los Angeles, CA, United States of America.

Weihao Zhou (W)

Center for Health Policy Research, University of California, Los Angeles (UCLA), Los Angeles, CA, United States of America.

Marlon Daniel (M)

Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. All work related to this manuscript was completed as an employee of Bureau of Primary Health Care, Health Resources and Services Administration, Rockville, MD, United States of America.

Hank Hoang (H)

Bureau of Primary Health Care, Health Resources and Services Administration, U.S. Department of Health and Human Services, Rockville, MD, United States of America.

Alek Sripipatana (A)

Bureau of Primary Health Care, Health Resources and Services Administration, U.S. Department of Health and Human Services, Rockville, MD, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH